1. Home
  2. WAY vs LEGN Comparison

WAY vs LEGN Comparison

Compare WAY & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAY
  • LEGN
  • Stock Information
  • Founded
  • WAY 1999
  • LEGN 2014
  • Country
  • WAY United States
  • LEGN United States
  • Employees
  • WAY N/A
  • LEGN N/A
  • Industry
  • WAY
  • LEGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • WAY
  • LEGN Health Care
  • Exchange
  • WAY Nasdaq
  • LEGN Nasdaq
  • Market Cap
  • WAY 6.2B
  • LEGN 5.4B
  • IPO Year
  • WAY 2024
  • LEGN 2020
  • Fundamental
  • Price
  • WAY $36.24
  • LEGN $35.56
  • Analyst Decision
  • WAY Strong Buy
  • LEGN Strong Buy
  • Analyst Count
  • WAY 11
  • LEGN 10
  • Target Price
  • WAY $44.73
  • LEGN $73.67
  • AVG Volume (30 Days)
  • WAY 1.7M
  • LEGN 1.1M
  • Earning Date
  • WAY 07-30-2025
  • LEGN 08-11-2025
  • Dividend Yield
  • WAY N/A
  • LEGN N/A
  • EPS Growth
  • WAY N/A
  • LEGN N/A
  • EPS
  • WAY 0.48
  • LEGN N/A
  • Revenue
  • WAY $1,011,303,000.00
  • LEGN $796,838,000.00
  • Revenue This Year
  • WAY $9.59
  • LEGN $70.75
  • Revenue Next Year
  • WAY $9.38
  • LEGN $52.47
  • P/E Ratio
  • WAY $74.91
  • LEGN N/A
  • Revenue Growth
  • WAY 17.14
  • LEGN 74.75
  • 52 Week Low
  • WAY $25.76
  • LEGN $27.34
  • 52 Week High
  • WAY $48.11
  • LEGN $59.62
  • Technical
  • Relative Strength Index (RSI)
  • WAY 52.13
  • LEGN 35.54
  • Support Level
  • WAY $34.76
  • LEGN $35.10
  • Resistance Level
  • WAY $36.48
  • LEGN $38.35
  • Average True Range (ATR)
  • WAY 0.91
  • LEGN 1.31
  • MACD
  • WAY 0.24
  • LEGN -0.37
  • Stochastic Oscillator
  • WAY 91.56
  • LEGN 11.33

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: